Newamsterdam Pharma Company Nv Stock (NAMS) Forecast
The Newamsterdam Pharma Company Nv (NAMS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $16.92, representing a -11.48% decrease from the current price of $19.12. The highest analyst price target is $18.86, and the lowest is $14.98.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NAMS Price Target
Average 25.68 (+34.30% Downside)
Is Newamsterdam Pharma Company Nv (NAMS) A Buy Now?
Oscillators
Buy: 1 · Sell: 2 · Neutral: 4Summary: Neutral
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, NAMS could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on NAMS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.66 indicates that NAMS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 23.76 indicates that NAMS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 35.91 indicates that NAMS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 21.58 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of -159.27 indicates that NAMS is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NAMS price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Newamsterdam Pharma Company Nv financial reports and earnings history, Newamsterdam Pharma Company Nv (NAMS) stock could reach $53.81 by 2030, $106.38 by 2040 and $145.87 by 2050. See the projected annual prices until 2050 of the Newamsterdam Pharma Company Nv stock below:
- Newamsterdam Pharma Company Nv (NAMS) is expected to reach an average price of $59.74 in 2035, with a high prediction of $64.40 and a low estimate of $49.89. This indicates an +212.45% change from the last recorded price of $19.12.
- Newamsterdam Pharma Company Nv (NAMS) stock is projected to chart a bullish course in 2040, with an average price target of $91.48, representing an +378.43% change from its current level. The forecast ranges from a conservative $88.76 to a sky-high $106.38.
- Our analysts predict Newamsterdam Pharma Company Nv (NAMS) to change +372.07% by 2045, soaring from $68.91 to an average price of $90.26, potentially reaching $91.83. While $68.91 is the low estimate, the potential upside is significant.
- Newamsterdam Pharma Company Nv (NAMS) stock is expected to climb by 2050, reaching an average of $143.51, a +650.58% change from its current level. However, a wide range of estimates exists, with high and low targets of $145.87 and $106.38, respectively, highlighting the market's uncertainty.
Newamsterdam Pharma Company Nv Stock (NAMS) Year by Year Forecast
Newamsterdam Pharma Company Nv Stock (NAMS) Price Forecast for 2026
The predicted value for Newamsterdam Pharma Company Nv (NAMS) in 2026 is set at an average of $27.23. Estimates vary from a peak of $42.21 to a trough of $14.98, indicating an +42.39% surge from the present price of $19.12.
Newamsterdam Pharma Company Nv Stock (NAMS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Newamsterdam Pharma Company Nv (NAMS) is $28.37, with a high forecast of $36.37 and a low forecast of $16.00. This indicates an +48.40% increase from the last price of $19.12.
Newamsterdam Pharma Company Nv Stock (NAMS) Price Forecast for 2028
In 2028, Newamsterdam Pharma Company Nv (NAMS) is projected to reach an average price of $33.13, with a high projection of $39.63 and a low estimate of $26.95. This indicates an +73.25% rise from the last price of $19.12.
Newamsterdam Pharma Company Nv Stock (NAMS) Price Forecast for 2029
The 2029 price forecast for Newamsterdam Pharma Company Nv Stock (NAMS) is $47.68 on average, with a high prediction of $58.25 and a low estimate of $35.17. This represents an +149.36% increase from the previous price of $19.12.
Newamsterdam Pharma Company Nv Stock (NAMS) Price Forecast for 2030
Newamsterdam Pharma Company Nv Stock (NAMS) is expected to reach an average price of $36.84 in 2030, with a high forecast of $53.81 and a low forecast of $24.34. This signifies an +92.70% surge from the last price of $19.12.
